BLFS · As filed with the SEC
Biolife Solutions balance sheet, by quarter
The statement as Biolife Solutions presents it in its 10-Q and 10-K: its own lines, labels and order. Tables over time lines up standardized figures across every filing.
Unaudited Condensed Consolidated Balance Sheets · USD thousands
| USD thousands | Q2 2026 Jun 30, 2026 | Q1 2026 Mar 31, 2026 | Q4 2025 Dec 31, 2025 | Q3 2025 Sep 30, 2025 | Q2 2025 Jun 30, 2025 | Q1 2025 Mar 31, 2025 | Q4 2024 Dec 31, 2024 | Q3 2024 Sep 30, 2024 |
|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||
| Current assets: | ||||||||
| Cash and cash equivalents | 23,997 | 22,822 | 33,038 | 29,481 | 31,902 | 66,945 | 95,386 | 23,977 |
| Restricted cash | — | — | — | — | — | — | — | 184 |
| Available-for-sale securities, current portion | 58,419 | 58,174 | 55,889 | 49,473 | 49,864 | 21,635 | 9,198 | 10,211 |
| Accounts receivable, trade, net of allowance for credit losses of $16 and $22 as of June 30, 2026 and December 31, 2025, respectively | 10,652 | 13,057 | 7,953 | 10,842 | 10,060 | 9,167 | 9,168 | 17,918 |
| Inventories | 35,591 | 32,834 | 30,155 | 27,825 | 27,690 | 27,566 | 29,013 | 32,179 |
| Prepaid expenses and other current assets | 6,539 | 6,335 | 9,526 | 8,945 | 5,916 | 5,816 | 5,996 | 4,914 |
| Current assets, discontinued operations | — | — | 0 | — | — | — | 0 | 0 |
| Total current assets | 135,198 | 133,222 | 136,561 | 126,566 | 125,432 | 131,129 | 148,761 | 89,383 |
| Assets held for rent, net | — | — | — | 5,164 | 5,307 | 5,690 | 6,103 | 10,822 |
| Property and equipment, net | 15,235 | 14,504 | 14,713 | 11,101 | 7,665 | 6,605 | 6,084 | 17,709 |
| Operating lease right-of-use assets, net | 8,644 | 7,113 | 7,466 | 7,633 | 9,534 | 10,128 | 10,674 | 14,402 |
| Financing lease right-of-use assets, net | — | — | — | — | — | — | — | 30 |
| Long-term deposits and other assets | — | — | — | — | 378 | 378 | 379 | 271 |
| Other assets | 3,289 | 3,049 | 3,050 | 2,419 | — | — | — | — |
| Available-for-sale securities, long-term | 30,654 | 30,499 | 31,250 | 19,444 | 18,471 | 19,055 | 4,628 | 4,884 |
| Equity investments | — | — | — | — | — | — | — | 995 |
| Equity investments | — | — | 0 | 0 | 0 | 995 | 995 | — |
| Intangible assets, net | 3,654 | 3,932 | 4,257 | 7,450 | 8,149 | 8,857 | 9,559 | 18,415 |
| Deferred tax assets, net | 42,233 | — | — | — | — | — | — | — |
| Goodwill | 208,587 | 208,587 | 208,587 | 212,304 | 212,304 | 212,304 | 212,304 | 224,741 |
| Long-term assets, discontinued operations | — | — | 0 | — | — | — | 0 | 0 |
| Total assets | 447,494 | 400,906 | 405,884 | 392,081 | 387,240 | 395,141 | 399,487 | 381,652 |
| Liabilities and Shareholders’ Equity | ||||||||
| Current liabilities: | ||||||||
| Accounts payable | 2,482 | 3,750 | 1,486 | 2,890 | 3,209 | 3,297 | 3,573 | 3,838 |
| Accrued expenses and other current liabilities | 6,798 | 7,575 | 11,974 | 10,905 | 9,311 | 8,213 | 12,451 | 8,449 |
| Sales taxes payable | 2,074 | 2,113 | 2,279 | 3,681 | 3,575 | 3,929 | 4,256 | 4,351 |
| Warranty liability | — | — | — | — | — | — | — | 186 |
| Lease liabilities, operating, current portion | 2,593 | 2,316 | 2,243 | 2,178 | 2,166 | 1,835 | 1,511 | 2,788 |
| Lease liabilities, financing, current portion | — | — | — | — | — | — | — | 323 |
| Debt, current portion | 0 | 2,499 | 4,997 | 7,492 | 10,051 | 10,449 | 10,943 | 12,231 |
| Current liabilities, discontinued operations | — | — | 0 | — | — | — | 0 | 0 |
| Total current liabilities | 13,947 | 18,253 | 22,979 | 27,146 | 28,312 | 27,723 | 32,734 | 32,166 |
| Lease liabilities, operating, long-term | 13,145 | 10,042 | 10,657 | 11,007 | 11,598 | 12,165 | 12,723 | 15,189 |
| Lease liabilities, financing, long-term | — | — | — | — | — | — | — | 913 |
| Debt, long-term | — | — | 0 | 0 | 0 | 2,499 | 4,997 | 7,823 |
| Deferred tax liabilities | 0 | 198 | 189 | 189 | 175 | 130 | 124 | 100 |
| Other long-term liabilities | 399 | 183 | 171 | — | — | — | — | — |
| Long-term liabilities, discontinued operations | — | — | 0 | — | — | — | 0 | 0 |
| Total liabilities | 27,491 | 28,676 | 33,996 | 38,342 | 40,085 | 42,517 | 50,578 | 56,191 |
| Shareholders’ equity: | ||||||||
| Preferred stock, $0.001 par value; 1,000,000 shares authorized, Series A, 4,250 shares designated, and 0 shares issued and outstanding as of June 30, 2026 and December 31, 2025 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Common stock, $0.001 par value; 150,000,000 shares authorized, 48,889,090 and 48,198,928 shares issued and outstanding, respectively, as of June 30, 2026 and December 31, 2025 | 49 | 49 | 48 | 48 | 48 | 48 | 47 | 46 |
| Additional paid-in capital | 713,571 | 710,811 | 711,404 | 704,327 | 698,423 | 688,092 | 683,939 | 673,183 |
| Accumulated other comprehensive (loss) income, net of tax | (211) | (120) | 132 | 130 | 71 | 33 | 24 | (208) |
| Accumulated deficit | (293,406) | (338,510) | (339,696) | (350,766) | (351,387) | (335,549) | (335,101) | (347,560) |
| Total shareholders’ equity | 420,003 | 372,230 | 371,888 | 353,739 | 347,155 | 352,624 | 348,909 | 325,461 |
| Total liabilities and shareholders’ equity | 447,494 | 400,906 | 405,884 | 392,081 | 387,240 | 395,141 | 399,487 | 381,652 |
As filed on EDGAR · Not affiliated with the U.S. SEC · Not investment advice. Each column links to its filing.